ReP USP - Resultado da busca

Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein (2016)

Ortega, Juliana Festa; Conti, Aline de; Tryndyak, Volodymyr; Furtado, kelly Silva; Heidor, Renato ; Horst, Maria Aderuza; Fernandes, Laura Helena Gasparini; Tavares, Paulo Eduardo Latorre Martins; Pogribna, Marta; Shpyleva, Svitlana; Beland, Frederick A; Pogribny, Igor P; Moreno, Fernando Salvador

Source: Oncotarget. Unidade: FCF

Subjects: HEPATOPATIAS, CARCINOMA HEPATOCELULAR

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT
ORTEGA, Juliana Festa et al. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget, v. 7, n. 17, p. 24339-24347, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.8248. Acesso em: 18 nov. 2024.
APA
Ortega, J. F., Conti, A. de, Tryndyak, V., Furtado, kelly S., Heidor, R., Horst, M. A., et al. (2016). Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget, 7( 17), 24339-24347. doi:10.18632/oncotarget.8248
NLM
Ortega JF, Conti A de, Tryndyak V, Furtado kelly S, Heidor R, Horst MA, Fernandes LHG, Tavares PELM, Pogribna M, Shpyleva S, Beland FA, Pogribny IP, Moreno FS. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein [Internet]. Oncotarget. 2016 ; 7( 17): 24339-24347.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.8248
Vancouver
Ortega JF, Conti A de, Tryndyak V, Furtado kelly S, Heidor R, Horst MA, Fernandes LHG, Tavares PELM, Pogribna M, Shpyleva S, Beland FA, Pogribny IP, Moreno FS. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein [Internet]. Oncotarget. 2016 ; 7( 17): 24339-24347.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.8248

USP Schools

ReP

Filtros

Authors